Other alterations are less well defined in terms of their contribution to the final neoplastic phenotype, and include activation of Src, which has been shown in up to 300% of breast cancers by our lab and others
ions and cofactors affecting the susceptibility of a murine PrPC substrate to seeded PrPres...